James Hattersley

SVP Business Development, Adherium LTD

James E. Hattersley currently serves as SVP Business Development on the executive management team of Adherium LTD., responsible for the operations of Adherium North America Inc., a global leader in digital health technologies addressing sub-optimal medication use in chronic disease states.  Adherium's primary area of focus is improvement of respiratory product outcomes, specifically asthma and COPD, in addition to several strategic areas and interest beyond the respiratory field.

Prior to Adherium, Mr. Hattersley held the position of Vice President of Business Development at Nektar Therapeutics.  Primary responsibilities at Nektar included business development, corporate strategic alliances, sourcing of commercial partners for Nektar's late stage clinical assets in oncology and pain management, and alliance management.

Previously, Mr. Hattersley served for several years as Vice President of Business Development at Sun Pharmaceutical Industries directly responsible for acquisitions and strategic partnerships in North America.  Select out-licensing transactions in Japan territory where presented, regarding oncology, ophthalmology, CNS, respiratory, and medical dermatology assets.

During the course of his career Mr. Hattersley has successfully completed numerous revenue-generating partnerships, at both the development and commercial stage, including small and mid/large cap multi-national pharmaceutical sector across North America, Europe, and Asia-Pacific regions. Transactions were significant in important therapeutic areas, including oncology, ophthalmology, CNS, respiratory, and medical dermatology fields.  Mr. Hattersley has over 25 years of successful leadership experience in the life sciences industry, demonstrating a proven track record of identifying and executing transactions of significant value.  Accomplishments have occured by integrating scientific training together with extensive domestic and international business experience. 

Mr. Hattersley earned both graduate and undergraduate degrees in biochemistry and neurobiology, respectively, from the University of California.  In addition, post-graduate executive completed at University of Chicago GSB in financial analytics.


MeEt Us

View our upcoming events

View All Events